Priya Sachdeva

Stock Analyst at UBS

(2.10)

# 2,845

Out of 4,761 analysts

3

Total ratings

66.67%

Success rate

3.66%

Average return

Main Sectors:

Top Industries:

Medical Devices

Stocks Rated by Priya Sachdeva

	Stock	Action	Price Target	Current	Upside	Ratings	Updated
	PEN Penumbra	Maintains: Buy	$305 → $320	$291.68	+9.71%	2	Feb 19, 2025
	NPCE NeuroPace	Initiates: Buy	$17	$13.77	+23.46%	1	Jan 21, 2025

Penumbra

Feb 19, 2025

Maintains: Buy

Price Target: $305 → $320

Current: $291.68

Upside: +9.71%

NeuroPace

Jan 21, 2025

Initiates: Buy

Price Target: $17

Current: $13.77

Upside: +23.46%